Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Duolingo rings up $35m
CMU-founded language learning platform developer Duolingo has now raised $183m altogether and has increased its valuation 60% to $2.4bn.
Cowen ticks Toronto’s boxes
Prof Leah Cowen will be University of Toronto’s first associate vice-president for research, building on expertise that includes being a co-founder of spinout Bright Angel Therapeutics.
Metcalf matches with The Engine
The Engine has appointed Lara Metcalf as CFO and COO, a month after raising a $230m second fund backed by MIT and Harvard.
Wyss Institute launches $12m alliance
Harvard University’s Wyss Institute has partnered Northpond Labs to create a research and innovation alliance equipped with $12m in funding.
Juventas packs in Parkland-backed round
The property developer has backed Chinese Academy of Medical Sciences spinout Juventas to help advance its clinical-stage oncology cell therapy candidates.
Daily deal net: November 19, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Umoja taps into $53m series A
MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.
Ellis leaves OSU
Zachary Ellis was the director of new ventures at Ohio State University for over three years but has left to join the institution’s long-time partner Rev1 Ventures.

News Continued

Mallon makes his way back to CIT
Sean Mallon had left CIT in 2016 to become associate vice-president for entrepreneurship and innovation at George Mason University.
Kandou caps off series C round
EPFL’s chip-link technology provider has added more than $36m to a Swisscom-backed round that now totals $92.3m, taking its total funding to almost $133m.
4DMT retries IPO with $75m filing
Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.
Leslie leaves VCU Ventures for Hampton Roads
Kevin Leslie, associate director of VCU Ventures, has moved on to become executive director of Hampton Roads Biomedical Research Consortium.
Hitachi spotlights VLC Photonics purchase
Polytechnic University of Valencia spinout VLC Photonics has been bought by Hitachi for an undisclosed sum nine years after it was founded.
Nereid tackles $50m series A
Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg